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Abstract
Background: Seasonal flu epidemics in the European region cause high numbers of cases and
deaths. Flu-associated mortality has been estimated but morbidity studies are necessary to
understand the burden of disease in the population. Our objective was to estimate the excess
hospital admissions in Spain of diseases associated with influenza during four epidemic influenza
periods (2000 – 2004).
Methods: Hospital discharge registers containing pneumonia, chronic bronchitis, heart failure and
flu from all public hospitals in Spain were reviewed for the years 2000 to 2004. Epidemic periods
were defined by data from the Sentinel Surveillance System. Excess hospitalisations were calculated
as the difference between the average number of weekly hospitalisations/100,000 in epidemic and
non-epidemic periods. Flu epidemics were defined for seasons 2001/2002, 2002/2003, 2003/2004.
Results: A(H3N2) was the dominant circulating serotype in 2001/2002 and 2003/2004. Negligible
excess hospitalisations were observed during the 2002/2003 epidemic where A(H1N1) was
circulating. During 2000/2001, flu activity remained below threshold levels and therefore no
epidemic period was defined. In two epidemic periods studied a delay between the peak of the
influenza epidemic and the peak of hospitalisations was observed. During flu epidemics with
A(H3N2), excess hospitalisations were higher in men and in persons <5 and >64 years higher than
10 per 100,000. Pneumonia accounted for 70% of all flu associated hospitalisations followed by
chronic bronchitis. No excess flu-specific hospitalisations were recorded during all seasons.
Conclusion: Flu epidemics have an impact on hospital morbidity in Spain. Further studies that
include other variables, such as temperature and humidity, are necessary and will deepen our
understanding of the role of each factor during flu epidemics and their relation with morbidity.
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Background
Influenza virus causes an acute disease of the respiratory
pathways, with high potential for person to person trans-
mission. The World Health Organization (WHO) esti-
mates that there are approximately 3 to 5 million cases
and 250,000–500,000 deaths due to flu each year world-
wide [1]. Flu epidemics in the European Region occur
annually during the winter season causing a high number
of cases and deaths.
With the introduction of the flu vaccine the number of
influenza cases and deaths have decreased significantly,
especially in vulnerable groups [2,3]. In Spain, the flu vac-
cine was introduced in the early 1980s. Since then studies
have showed that flu vaccination prevents hospital admis-
sions for pneumonia in persons older than 65 years (OR
= 0.21, CI95% = 0.09–0.55) [4] and is 22% effective in
preventing mortality in persons over 75 with chronic dis-
ease [5]. The Ministry of Health vaccination guidelines
from 1992 recommend flu vaccinations to persons above
65 years of age, persons younger than 65 years who for
medical reasons have a higher risk of developing flu com-
plications, their caretakers and healthcare staff. Between
1993 and 2001, the vaccination coverage in persons with
chronic medical conditions, was estimated to be 31.2%
for those younger than 65 years and 46.0% for persons
older than 65 years [6]. A recent study estimated that 18
million persons, 41% of the Spanish population, should
receive influenza vaccination in the 2006–2007 season
according to the Spanish guidelines[7].
Despite the availability of the flu vaccine, flu and the dis-
eases associated with it continue to be an important pub-
lic health issue. Flu-associated mortality has been
estimated in several studies elsewhere [8-12]. However,
this mortality does not represent the actual burden of the
disease in the population as only a small proportion of
severe flu cases are fatal [8,13,14]. Estimating the number
of influenza associated cases better reflects better the bur-
den of disease in the population. Recent studies have
shown that influenza-associated hospital based morbidity
in the United States, Canada, England and Wales and
Hong Kong, is higher in children younger than 2 years and
in persons older than 65 years [10,15-20]. A study in the
Spanish Basque Country, showed that hospitalisation
rates in children under 5 years were higher during influ-
enza epidemics [21]. The impact on hospital admissions
has not yet been measured for the rest of the country or in
other age groups.
Our objective was to estimate the excess hospital admis-
sions in Spain of diseases associated with influenza, dur-
ing four epidemic influenza periods by gender, vulnerable
groups and according to the circulating dominant influ-
enza serotype in order to improve the existing prevention
and vaccination programmes and the planning of health-
care resources.
Methods
Hospitalisation
We defined all-cause flu-associated hospitalisation as a
patient who was discharged from hospital with pneumo-
nia, chronic bronchitis (CB), heart failure (HF) and flu
present in at least one of the 10 possible diagnostic fields.
These diseases were selected as they are most related to
flu-associated morbidity based in existing bibliography.
We included all diagnostic fields so as to ensure the cap-
ture of all hospitalisations for diseases possibly associated
with influenza.
Hospital discharge registers, also know as the Minimum
Basic Set of Data (MBSD), were reviewed from all public
hospitals for the years 2000 to 2004. For pneumonia we
included ICD9-CM codes 480–486, which correspond to
pneumonias due to all viral, bacterial and unknown
causes. The ICD9-CM codes for CB included non-specific
bronchitis, chronic bronchitis and emphysema (ICD9-
CM: 490–492). For HF we selected ICD9-CM codes corre-
sponding to congestive heart failure, non-specific heart
failure and other specific and non-specific chronic cardio-
pulmonary conditions (ICD9-CM: 428.0, 428.9, 416.8 y
416.9). For flu we used influenza: ICD9-CM code 487,
which is influenza.
Definition of epidemic and non-epidemic flu periods
Information on the circulation of flu is collected each year
between epidemiological weeks 40 and 20 by the Spanish
Influenza Sentinel Surveillance System (SISS) [22].
Briefly, the surveillance system uses sentinel general prac-
titioners and paediatricians (538 during last flu season),
who notify weekly the number of consultations for influ-
enza-like illness (ILI) in their reference populations. In
addition, general practitioners regularly send samples for
virological confirmation to the sentinel laboratories in
their region. This allows the genetic and antigenic charac-
terisation of the influenza virus' circulating during each
surveillance period. Each week, a global population
adjusted influenza rate for Spain is calculated to follow
the evolution of influenza activity. The sentinel surveil-
lance system for influenza covers approximately 75% of
the population nationwide.
Threshold incidence rates for epidemic influenza activity
are defined for each surveillance season, using the mean
incidence rates from the previous 5 years of surveillance.
The viral isolation rate is estimated as the percentage of
positive viral isolations out of the total number of respira-
tory samples sent to the laboratory.BMC Public Health 2007, 7:197 http://www.biomedcentral.com/1471-2458/7/197
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We defined an 'epidemic' period as the interval of weeks
between epidemiological weeks 40 and 20 of the winter
season with an incidence rate for flu over passing the
threshold for that flu season and a viral isolation rate
higher than 30%. The non-epidemic period was defined
as the interval of weeks between epidemiological weeks
40 and 20 not corresponding to the epidemic period.
Analysis
To study the evolution of the influenza epidemics and
hospitalisation rates during influenza surveillance sea-
sons, we compared the ILI incidence rates per week and
the weekly hospitalisation rates (number of hospital
admissions/week/population) for all flu-associated dis-
eases.
We calculated average weekly hospital admissions per
100,000 population for the epidemic and non-epidemic
period of the flu season separately. We defined the excess
hospital disease burden as the difference between weekly
hospital admissions per 100,000 inhabitants for the epi-
demic and the non-epidemic period. Hospitalisation rates
were calculated during each period for all-cause, pneumo-
nia, CB, HF and flu and for the overall population, by sex
and age group (under 5 years and over 64 years). Confi-
dence intervals of 95% were calculated for all weekly
admission rates.
Population figures for age and sex were obtained from the
Spanish National Institute of Statistics. We used the pop-
ulation for the second year of a flu season as the denomi-
nator. For example, for the 2000/2001 flu season (S1), the
population data for the year 2001 were used.
This study required no ethical approval as the data used
for the study was obtained from anonymous data from
hospital discharge registers and the influenza surveillance
system with no personal identifier codes or information
available.
Results
Epidemic periods and circulating serotypes
In S1 no epidemic flu period could be defined as the max-
imum weekly ILI incidence (37.6 cases per 100,000) was
below the epidemic threshold. The highest weekly flu
incidence recorded for the four seasons was during 2001/
2002 (S2), when incidence rates reached 312.2 cases per
100,000, followed by 2003/2004 (S4) with 225.0 cases
per 100000 and finally 2002/2003 (S3) with 139.3 cases
per 100000 (Figure 1). The duration of the epidemic
period was 12 weeks in S2, 14 weeks in S3 and 10 weeks
in S4 (Figure 1).
Influenza B was the dominant circulating serotype during
the S1 season. In S3 both influenza B and A(H1N1) were
circulating with influenza B as the dominant serotype.
Influenza A(H3N2) was the dominant serotype detected
circulating in both the S2 and S4 seasons (Additional file
1).
All-cause influenza-associated hospital admissions and ILI 
rates
From week 40 to 20 hospital admission rates for all-cause
flu-associated disease were 247 (100,102 cases), 180
(73,358 cases) and 177 (72,481 cases) per 100.000 inhab-
itants in S2, S3 and S4 respectively (Figure 1). In S2 a peak
was reached for all cause hospitalisations between weeks
52 and 5; and for ILI incidence between weeks 4 and 6. In
S3 hospitalisations remained constant and ILI incidence
peaked in weeks 4 and 5. In S4 the peak in hospitalisa-
tions occurred in weeks 52 and 1 and ILI incidence peaked
in week 47.
All age excess hospital admissions
For the defined epidemic periods in S2 and S4 there was
an excess in all cause flu-associated hospitalisations. In S3
hospital admissions in both the defined epidemic and
non-epidemic periods were similar (Additional file 1).
During S2 and S4 the excess hospitalisations per 100, 000
were higher in men compared to women (Figure 2); 4.81
in men and 3.01 in women in S2 and 0.93 in men and
0.79 in women in S4. In S3 no excess all-cause hospitali-
sations were recorded during the epidemic period for men
and women.
A total of 120,407, 88,618 and 88,497 flu-associated dis-
eases were registered for S2, S3, S4. Amongst a total of
209,698 pneumonia diagnoses, 91% were registered as
the principal or secondary field of the MBSD (i.e. reason
for hospital admission). The number of hospital admis-
sions reported as principal or secondary diagnosis was
48,857 (62%) for CB and 37,389 (35%) for overall for all
three seasons. Among the 1578 reported flu cases 88%
were reported as primary or secondary diagnostic in the
MBSD.
Pneumonia was the most common of all flu-associated
diseases. In S2, 79,836 (66%) of all flu-associated diag-
noses included in this study were due to pneumonia,
regardless of epidemic period. This proportion was higher
in S3 and the S4 season where pneumonia accounted for
63,644 (71%) and 66,218 (75%) hospital diagnoses
respectively. In all three epidemic periods, hospital admis-
sions for pneumonia were always in excess, with the high-
est for S2, followed by S4 and S3 (Additional file 1).
CB hospitalisations were the second most common flu-
associated disease during the seasons studied, 22,892
(19%), 13,913 (16%) and 12,052 (14%) for S2, S3 and S4
respectively. The maximum number of hospitalisationsBMC Public Health 2007, 7:197 http://www.biomedcentral.com/1471-2458/7/197
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for CB occurred during the epidemic period of S2 with 2.2
cases per 100,000 (Additional file 1). During S3, a nega-
tive excess morbidity was calculated. In S4 excess hospital-
isations were less than 1 case per 100,000.
Hospitalisations with HF diagnosis represented 14% (n =
17323), 12% (n = 10655) and 10% (n = 9411) of all flu
associated diagnoses for S2, S3 and S4 respectively. Excess
HF hospital morbidity was recorded for the S2 and S4 sea-
sons, with similar rates in both (Additional file 1). For the
S3 season there was no excess in overall hospital admis-
sions for HF.
No excess morbidity for flu specific hospitalisations was
recorded in S2, S3 or S4 (Additional file 1).
Persons below 5 years and over 64 years
The two age groups with highest number of flu-associated
hospitalisations regardless of epidemic period were chil-
dren under 5 years and persons above 64 years of age. In
these age groups, excess hospital burden is the highest.
Excess all-cause hospitalisations during epidemic periods
exceed 10 cases per 100,000 in both age groups during S2
and S4 (Additional file 2). This excess is negligible during
S3.
In children under 5 years, pneumonia was the principal
reason for excess admissions during the flu epidemic in
both S2 and S4, accounting for 98% and 99% of all excess
all-cause hospital morbidity calculated for these seasons
(Additional file 2). Excess hospitalisations for CB, HF and
flu were below 1 per 100,000 during all three seasons in
this age group.
For persons above 65 years the highest excess hospital
burden was for pneumonia during all three seasons
(Additional file 2). During S3 this excess was 87% and
89% lower than in S2 and S4 respectively. HF and CB had
similar excess hospitalisations during all three seasons,
being negligible during S3. For flu, excess hospital mor-
bidity remained below 1 case per 100,000 during epi-
demic periods for all three seasons.
Discussion
Our results suggest that during the studied influenza sea-
sons there was an impact of flu epidemics on hospital
admissions in Spain. As has been described in other stud-
Hospitalisation rates for all flu associated diseases and ILI incidence rates (both per 100,000 inhabitants) per epidemiological  week in Spain during influenza seasons 2001/2002, 2002/2003 and 2003/2004 Figure 1
Hospitalisation rates for all flu associated diseases and ILI incidence rates (both per 100,000 inhabitants) per epidemiological 
week in Spain during influenza seasons 2001/2002, 2002/2003 and 2003/2004.
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ies [8,16,17], the impact of flu appears to be greater when
A(H3N2) is the dominating circulating serotype of the
virus, which is similar to our results from the epidemic
periods of S2 and S4. This suggests that A(H3N2) is a
more virulent serotype, thereby causing more severe clin-
ical manifestations leading to hospitalisation. In our
study pneumonia was the main flu-associated disease
causing hospitalisations and persons below 5 years and
over 64 years of age were the most vulnerable for hospital-
isation during flu epidemics, as has been shown in previ-
ous studies [10,16-21].
In two of three flu epidemics studied there is a delay
observed between the peak of the influenza epidemics
and the peak in all-cause-flu-associated hospitalisations.
One possible explanation of the delay would be that
underlying medical conditions do not deteriorate imme-
diately in persons infected with influenza. The time
between infection and need for hospitalisation could
reflect the delay seen in S3 and S4.
In our study we may have overestimated the excess disease
burden in hospitals. Firstly, by including ten diagnostic
fields from the hospital discharge registers, we could be
overestimating the number of hospitalisations associated
with flu. However, we have observed that a high propor-
tion of the included flu-associated diseases were reported
as principal or secondary diagnosis, reflecting that these
clinical manifestations were likely to be related to the
actual reason for hospital admission. Secondly, hospital
discharge registers do not include laboratory information
(i.e. influenza confirmation), limiting our capacity to esti-
mate the real number of hospitalisations from influenza
infection. Part of the hospitalisations that we have consid-
ered to be flu-associated might in fact be due to parainflu-
enza virus, respiratory synctical virus (RSV) or adenovirus
[10,23]. It is likely that different respiratory virus' have dif-
ferent effects in different age groups. As was found by Mul-
looly et al., influenza infection in persons above 65 years
of age and with underlying chronic pathologies was a
stronger risk factor for hospitalisations for cardiac reasons
than RSV infection [24]. In contrast, children under 5
months of age showed the highest rates for emergency
department visits for respiratory infections in winter
months due to RSV, whereas children between 6 and 23
months reported emergency department visits for influ-
enza related infections [25].
The overestimation of the impact of flu on hospital
admissions is especially a limitation if one wants to calcu-
late in economical terms the burden of influenza in hos-
pitals [26]. Barker estimated that the total cost associated
with excess hospitalisations for pneumonia and influenza
during an influenza A epidemic was equal to $300 million
dollars in the United States [8]. Though prices for hospi-
talisation and size of population in Spain are different,
costs associated with excess hospital burden from influ-
enza associated pathologies could be substantial.
The MBSD does not include information on re-admis-
sions, limiting the identification of duplicate admissions
for the same disease in the same patient and therefore a
possible overestimation of hospitalisations. However, as
this limitation is present in all three seasons studied the
results obtained are still comparable between them. The
hospital discharge files also do not collect information
about underlying risk factors that can contribute to more
severe manifestations following influenza infection, such
as cardio-vascular, kidney and metabolic diseases and
anaemia [27].
Also, no information on flu vaccination history is availa-
ble and we have not been able to evaluate the role that
vaccination has in flu-associated hospital admissions dur-
ing epidemic flu periods. The analysis of National Health
Surveys conducted in 2001 and 2003 show that average
influenza vaccine coverage in Spain in persons under 65
years of age with chronic conditions (diabetes, asthma,
chronic bronchitis and heart disease) was 29.8% and
35.3% respectively [28]. In persons above 65 years of age
the average national vaccine coverage was determined to
be 56.09% and 63.7% in 2001 and 2003 respectively [28].
Our results show that particularly in persons over 65 years
of age, but also in those under 5, there were excess hospi-
tal admissions in periods of influenza A(H3N2) activity.
These findings encourage the continued use and strength-
ening of campaigns to increase vaccination coverage in
these age groups.
Excess average weekly hospitalisations in men and women  for all-cause hospitalisations per 100,000 during influenza epi- demics 2001/2002 (S2), 2002/2003 (S3) and 2003/2004 (S4)  in Spain Figure 2
Excess average weekly hospitalisations in men and women 
for all-cause hospitalisations per 100,000 during influenza epi-
demics 2001/2002 (S2), 2002/2003 (S3) and 2003/2004 (S4) 
in Spain.
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Data from the SISS, allowing the early identification of cir-
culating virulent serotypes and the start of epidemic peri-
ods, could be used to plan hospital resources for expected
increases in flu-associated admissions.
We also recommend that further studies try to quantify
the hospitalisation costs and days lost of work associated
to flu epidemics in order to evaluate what economical
impact flu epidemics suppose in Spain. The development
of time series models including variables such as temper-
ature, humidity, age group, sex, flu and other winter virus'
circulation, will allow a better understanding of the role
that each of these factors play during flu epidemics with
regards to flu-associated pathologies and their presence in
hospitals.
Conclusion
Flu epidemics have an impact on hospital morbidity in
Spain. Further studies that include other variables, such as
temperature and humidity are necessary and will deepen
our understanding of the role of each factor during flu epi-
demics and their relation with morbidity.
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